Eric Lawitz : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (213)
Les plus populaires
Liste
- Liste
- Tableau

1

Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study

Afdhal, Nezam H., Bacon, Bruce R., Patel, Keyur, Lawitz, Eric J., Gordon, Stuart C., Nelson, David R., Challies, Tracy L., Nasser, Imad, Garg, Jyotsna, Wei, Lee-Jen, McHutchison, John G.

Journal:

Clinical Gastroenterology and Hepatology

Année:

2015

Langue:

english

Fichier:

PDF, 826 KB

english, 2015

2

Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment

Mogalian, Erik, Brainard, Diana M., Osinusi, Anu, Moorehead, Lisa, Murray, Bernard, Ling, Kah Hiing John, Perry, Robert, Curtis, Craig, Lawitz, Eric, Lasseter, Kenneth, Marbury, Thomas, Mathias, Anita

Journal:

Clinical Pharmacokinetics

Année:

2018

Langue:

english

Fichier:

PDF, 726 KB

english, 2018

3

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding, Lindsay McNair, Molly Aalyson, J

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 240 KB

english, 2009

4

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Reddy, K. Rajender, Bourlière, Marc, Sulkowski, Mark, Omata, Masao, Zeuzem, Stefan, Feld, Jordan J., Lawitz, Eric, Marcellin, Patrick, Welzel, Tania M., Hyland, Robert, Ding, Xiao, Yang, Jenny, Knox,

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.79 MB

english, 2015

5

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Curry, Michael P., O’Leary, Jacqueline G., Bzowej, Natalie, Muir, Andrew J., Korenblat, Kevin M., Fenkel, Jonathan M., Reddy, K. Rajender, Lawitz, Eric, Flamm, Steven L., Schiano, Thomas, Teperman, Le

Journal:

New England Journal of Medicine

Année:

2015

Langue:

english

Fichier:

PDF, 204 KB

english, 2015

6

Hepatic Proton Density Fat Fraction Correlates with Histologic Measures of Steatosis and is Responsive to Change in those Measures in a Multi-Center Nonalcoholic Steatohepatitis Clinical Trial

Loomba, Rohit, Lawitz, Eric, Jayakumar, Saumya, Mantry, Parvez S., Caldwell, Stephen H., Diehl, Anna Mae, Peach, Matt, Xu, Ren, Djedjos, C. Stephen, Natha, Macky, Myers, Robert P., Subramanian, Mani,

Journal:

Gastroenterology

Année:

2017

Langue:

english

Fichier:

PDF, 870 KB

english, 2017

7

Improvement of Hepatic Fibrosis and Patient-Reported Outcomes in Non-Alcoholic Steatohepatitis Treated with Selonsertib

Younossi, Zobair M., Stepanova, Maria, Lawitz, Eric, Charlton, Michael, Loomba, Rohit, Myers, Robert P., Subramanian, G. Mani, McHutchison, John G., Goodman, Zachary

Journal:

Liver International

Année:

2018

Langue:

english

Fichier:

PDF, 462 KB

english, 2018

8

Su1522 - Proof of Concept Study of an Apoptosis-Signal Regulating Kinase (ASK-1) Inhibitor (Selonsertib) in Combination with an Acetyl-Coa Carboxylase Inhibitor (GS-0976) or a Farnesoid X Receptor (FXR) Agonist (GS-9674) in NASH

Lawitz, Eric, Herring, Robert, Younes, Ziad H., Gane, Edward, Ruane, Peter J., Aguilar, Raul, Jia, Catherine, Xu, Ren, McColgan, Bryan J., Natha, Macky, Djedjos, C. Stephen, Subramanian, Mani, McHutch

Journal:

Gastroenterology

Année:

2018

Langue:

english

Fichier:

PDF, 1019 KB

english, 2018

9

GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)

Alkhouri, Naim, Lawitz, Eric, Noureddin, Mazen, DeFronzo, Ralph, Shulman, Gerald I.

Journal:

Expert Opinion on Investigational Drugs

Année:

2019

Fichier:

PDF, 1.71 MB

2019

10

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

John G. McHutchison, Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz, Mitchell Shiffman, Nezam H. Afdhal, Ira M. Jacobson, Andrew Muir, Mohammed Al-Adhami, Mary L. Morris, Julie A. Lekstrom-Himes, Susan

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 397 KB

english, 2007

11

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C

Fred Poordad, Eric Lawitz, Mitchell L. Shiffman, Tarek Hassanein, Andrew J. Muir, Bruce R. Bacon, Jamie Heise, Deanine Halliman, Eric Chun, Janet Hammond

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 265 KB

english, 2010

12

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

Richard E. Nettles, Min Gao, Marc Bifano, Ellen Chung, Anna Persson, Thomas C. Marbury, Ronald Goldwater, Michael P. DeMicco, Maribel Rodriguez-Torres, Apinya Vutikullird, Ernesto Fuentes, Eric Lawitz

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 282 KB

english, 2011

13

Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti

Matthew J Hepburn, Eric J Lawitz

Journal:

BMC Gastroenterology

Année:

2004

Langue:

english

Fichier:

PDF, 451 KB

english, 2004

14

The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study

Matthew J Hepburn, Jeffrey A Vos, Eric P Fillman, Eric J Lawitz

Journal:

BMC Gastroenterology

Année:

2005

Langue:

english

Fichier:

PDF, 512 KB

english, 2005

15

Treatment of chronic hepatitis C in nonresponders to previous therapy

Todd E. Dantzler, Eric J. Lawitz

Journal:

Current Gastroenterology Reports

Année:

2003

Langue:

english

Fichier:

PDF, 375 KB

english, 2003

16

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

McHutchison, John G., Lawitz, Eric J., Shiffman, Mitchell L., Muir, Andrew J., Galler, Greg W., McCone, Jonathan, Nyberg, Lisa M., Lee, William M., Ghalib, Reem H., Schiff, Eugene R.

Journal:

New England Journal of Medicine

Année:

2009

Langue:

english

Fichier:

PDF, 266 KB

english, 2009

17

Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy

Eric Lawitz, Eliot Godofsky, Regine Rouzier, Thomas Marbury, Tuan Nguyen, June Ke, MeiMei Huang, Jens Praestgaard, Denise Serra, Thomas G. Evans

Journal:

Antiviral Research

Année:

2011

Langue:

english

Fichier:

PDF, 620 KB

english, 2011

18

Differences in treatment outcome for hepatitis C among ethnic groups

Matthew J Hepburn, Lisa M Hepburn, Norma S Cantu, Maria G Lapeer, Eric J Lawitz

Journal:

The American Journal of Medicine

Année:

2004

Langue:

english

Fichier:

PDF, 129 KB

english, 2004

19

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

Eric Lawitz, Maribel Rodriguez-Torres, Andrew J. Muir, Tara L. Kieffer, Lindsay McNair, Ariya Khunvichai, John G. McHutchison

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 594 KB

english, 2008

20

Evaluation of VCH-759 monotherapy in hepatitis C infection

Curtis Cooper, Eric J. Lawitz, Peter Ghali, Maribel Rodriguez-Torres, Frank H. Anderson, Samuel S. Lee, Jean Bédard, Nathalie Chauret, Roch Thibert, Isabel Boivin, Olivier Nicolas, Louise Proulx

Journal:

Journal of Hepatology

Année:

2009

Langue:

english

Fichier:

PDF, 279 KB

english, 2009

21

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Eric J. Lawitz, Daniel Gruener, John M. Hill, Thomas Marbury, Lisa Moorehead, Anita Mathias, Guofeng Cheng, John O. Link, Kelly A. Wong, Hongmei Mo, John G. McHutchison, Diana M. Brainard

Journal:

Journal of Hepatology

Année:

2012

Langue:

english

Fichier:

PDF, 830 KB

english, 2012

22

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Paul Y Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff, John M Vierling, David Pound, Mitchell N Davis, Joseph S Galati, Stuart C Gordon, Natarajan Ravendhran, Lorenzo Rossaro, Frank H Anderson,

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 378 KB

english, 2010

23

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Alexander J. Thompson, Andrew J. Muir, Mark S. Sulkowski, Dongliang Ge, Jacques Fellay, Kevin V. Shianna, Thomas Urban, Nezam H. Afdhal, Ira M. Jacobson, Rafael Esteban, Fred Poordad, Eric J. Lawitz,

Journal:

Gastroenterology

Année:

2010

Langue:

english

Fichier:

PDF, 1.60 MB

english, 2010

24

Cyclophilin Inhibitors for Hepatitis C Therapy

Fernando E. Membreno, Jennifer C. Espinales, Eric J. Lawitz

Journal:

Clinics in Liver Disease

Année:

2013

Langue:

english

Fichier:

PDF, 107 KB

english, 2013

25

Predictors of Oxygen Desaturation During Routine Gastrointestinal Endoscopy

Timothy Cassidy, Eric Lawitz, Peter Kobes, Richard Shaffer, Esther Sutton, Linda Johnson, Donna Jones, Jeannette Turullols, Mark Jeffries

Journal:

Gastrointestinal Endoscopy

Année:

2004

Langue:

english

Fichier:

PDF, 81 KB

english, 2004

26

Utility of preoperative fiberoptic flexible sigmoidoscopy in the evaluation of patients with suspected gynecologic malignancy

Eric Lawitz, Shailesh C. Kadakia

Journal:

Gastrointestinal Endoscopy

Année:

1998

Langue:

english

Fichier:

PDF, 204 KB

english, 1998

27

Response

Eric J. Lawitz, Shailesh C. Kadakia

Journal:

Gastrointestinal Endoscopy

Année:

1999

Langue:

english

Fichier:

PDF, 256 KB

english, 1999

28

Non-interferon Therapies for Hepatitis C

Fernando E. Membreno, Eric J. Lawitz

Journal:

Current Hepatitis Reports

Année:

2012

Langue:

english

Fichier:

PDF, 135 KB

english, 2012

29

The effect of hepatic steatosis on hepatic iron concentration in fresh and paraffin-embeded tissue

Peter W.K. Wong, Eric Lawitz, Sigurd Torgerson, Zachary Goodman, Jose Centeno

Journal:

American Journal of Gastroenterology

Année:

2001

Langue:

english

Fichier:

PDF, 25 KB

english, 2001

30

High Sustained Virologic Response (SVR) Among Genotype 1 Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Peginterferon Alfa-2A/Ribavirin

Steven L. Flamm, Eric J. Lawitz, Ira M. Jacobson, Raymond A. Rubin, Marc Bourliere, C. Hezode, J. Vierling, Claus Niederau, Morris Sherman, Venkata S. Goteti, Regis A. Vilchez, Clifford A. Brass, Jani

Journal:

Gastroenterology

Année:

2011

Langue:

english

Fichier:

PDF, 159 KB

english, 2011

31

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

David R. Nelson, Yves Benhamou, Wan–Long Chuang, Eric J. Lawitz, Maribel Rodriguez–Torres, Robert Flisiak, Jens W.F. Rasenack, Wiesław Kryczka, Chuan–Mo Lee, Vincent G. Bain, Stephen Pianko, Keyur Pat

Journal:

Gastroenterology

Année:

2010

Langue:

english

Fichier:

PDF, 981 KB

english, 2010

32

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1

Stefan Zeuzem, Mark S. Sulkowski, Eric J. Lawitz, Vinod K. Rustgi, Maribel Rodriguez–Torres, Bruce R. Bacon, Mircea Grigorescu, Alan D. Tice, Yoav Lurie, Janusz Cianciara, Andrew J. Muir, Patrick W. C

Journal:

Gastroenterology

Année:

2010

Langue:

english

Fichier:

PDF, 1.09 MB

english, 2010

33

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

Poordad, Fred, Lawitz, Eric, Kowdley, Kris V., Cohen, Daniel E., Podsadecki, Thomas, Siggelkow, Sara, Heckaman, Michele, Larsen, Lois, Menon, Rajeev, Koev, Gennadiy, Tripathi, Rakesh, Pilot-Matias, Ta

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 466 KB

english, 2013

34

Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure

Pol, Stanislas, Aerssens, Jeroen, Zeuzem, Stefan, Andreone, Pietro, Lawitz, Eric J., Roberts, Stuart, Younossi, Zobair, Foster, Graham R., Focaccia, Roberto, Horban, Andrzej, Pockros, Paul J., Van Hee

Journal:

Journal of Hepatology

Année:

2013

Langue:

english

Fichier:

PDF, 716 KB

english, 2013

35

Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial

Younossi, Zobair, Negro, Francesco, Serfaty, Lawrence, Pol, Stanislas, Diago, Moises, Zeuzem, Stefan, Andreone, Pietro, Lawitz, Eric J., Roberts, Stuart, Focaccia, Roberto, Foster, Graham R., Horban,

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 853 KB

english, 2013

36

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

Jacobson, Ira M., Gordon, Stuart C., Kowdley, Kris V., Yoshida, Eric M., Rodriguez-Torres, Maribel, Sulkowski, Mark S., Shiffman, Mitchell L., Lawitz, Eric, Everson, Gregory, Bennett, Michael, Schiff,

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 479 KB

english, 2013

37

Treatment of HCV Infection by Targeting MicroRNA

Janssen, Harry L.A., Reesink, Hendrik W., Lawitz, Eric J., Zeuzem, Stefan, Rodriguez-Torres, Maribel, Patel, Keyur, van der Meer, Adriaan J., Patick, Amy K., Chen, Alice, Zhou, Yi, Persson, Robert, Ki

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 1.95 MB

english, 2013

38

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Lawitz, Eric, Mangia, Alessandra, Wyles, David, Rodriguez-Torres, Maribel, Hassanein, Tarek, Gordon, Stuart C., Schultz, Michael, Davis, Mitchell N., Kayali, Zeid, Reddy, K. Rajender, Jacobson, Ira M.

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 440 KB

english, 2013

39

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bacon, Bruce R., Gordon, Stuart C., Lawitz, Eric, Marcellin, Patrick, Vierling, John M., Zeuzem, Stefan, Poordad, Fred, Goodman, Zachary D., Sings, Heather L., Boparai, Navdeep, Burroughs, Margaret, B

Journal:

Boston Medical and Surgical Journal

Année:

2011

Langue:

english

Fichier:

PDF, 623 KB

english, 2011

40

A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1

Lawitz, Eric, Poordad, Fred, Kowdley, Kris V., Cohen, Daniel E., Podsadecki, Thomas, Siggelkow, Sara, Larsen, Lois, Menon, Rajeev, Koev, Gennadiy, Tripathi, Rakesh, Pilot-Matias, Tami, Bernstein, Barr

Journal:

Journal of Hepatology

Année:

2013

Langue:

english

Fichier:

PDF, 530 KB

english, 2013

41

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial

Poordad, Fred, Lawitz, Eric, Reddy, K. Rajender, Afdhal, Nezam H., Hézode, Christophe, Zeuzem, Stefan, Lee, Samuel S., Calleja, Jose Luis, Brown, Robert S., Craxi, Antonio, Wedemeyer, Heiner, Nyberg,

Journal:

Gastroenterology

Année:

2013

Langue:

english

Fichier:

PDF, 1.67 MB

english, 2013

42

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

Lawitz, Eric, Lalezari, Jay P, Hassanein, Tarek, Kowdley, Kris V, Poordad, Fred F, Sheikh, Aasim M, Afdhal, Nezam H, Bernstein, David E, DeJesus, Edwin, Freilich, Bradley, Nelson, David R, Dieterich,

Journal:

The Lancet Infectious Diseases

Année:

2013

Langue:

english

Fichier:

PDF, 276 KB

english, 2013

43

Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection

Marcellin, Patrick, Cooper, Curtis, Balart, Luis, Larrey, Dominique, Box, Terry, Yoshida, Eric, Lawitz, Eric, Buggisch, Peter, Ferenci, Peter, Weltman, Martin, Labriola–Tompkins, Emily, Le Pogam, Soph

Journal:

Gastroenterology

Année:

2013

Langue:

english

Fichier:

PDF, 517 KB

english, 2013

44

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Lawitz, Eric, Poordad, Fred F, Pang, Phillip S, Hyland, Robert H, Ding, Xiao, Mo, Hongmei, Symonds, William T, McHutchison, John G, Membreno, Fernando E

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 400 KB

english, 2014

45

Boceprevir With Peginterferon Alfa-2aâRibavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

Flamm, Steven L., Lawitz, Eric, Jacobson, Ira, BourliÃ¨re, Marc, Hezode, Christophe, Vierling, John M., Bacon, Bruce R., Niederau, Claus, Sherman, Morris, Goteti, Venkata, Sings, Heather L., Barnard,

Journal:

Clinical Gastroenterology and Hepatology

Année:

2013

Langue:

english

Fichier:

PDF, 732 KB

english, 2013

46

Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized, Multicenter, Open-Label Study

Brady, Daniel E., Torres, Dawn M., An, Jong W., Ward, John A., Lawitz, Eric, Harrison, Stephen A.

Journal:

Clinical Gastroenterology and Hepatology

Année:

2010

Langue:

english

Fichier:

PDF, 576 KB

english, 2010

47

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Kowdley, Kris V, Lawitz, Eric, Crespo, Israel, Hassanein, Tarek, Davis, Mitchell N, DeMicco, Michael, Bernstein, David E, Afdhal, Nezam, Vierling, John M, Gordon, Stuart C, Anderson, Jane K, Hyland, R

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 241 KB

english, 2013

48

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial

Rodriguez-Torres, Maribel, Lawitz, Eric, Kowdley, Kris V., Nelson, David R., DeJesus, Edwin, McHutchison, John G., Cornpropst, Melanie T., Mader, Michael, Albanis, Efsevia, Jiang, Deyuan, Hebner, Chri

Journal:

Journal of Hepatology

Année:

2013

Langue:

english

Fichier:

PDF, 669 KB

english, 2013

49

Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C

Younossi, Zobair M., Stepanova, Maria, Henry, Linda, Gane, Edward, Jacobson, Ira M., Lawitz, Eric, Nelson, David, Gerber, Lynn, Nader, Fatema, Hunt, Sharon

Journal:

Clinical Gastroenterology and Hepatology

Année:

2014

Langue:

english

Fichier:

PDF, 937 KB

english, 2014

50

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Everson, Gregory T., Sims, Karen D., Rodriguez-Torres, Maribel, Hézode, Christophe, Lawitz, Eric, Bourlière, Marc, Loustaud-Ratti, Veronique, Rustgi, Vinod, Schwartz, Howard, Tatum, Harvey, Marcellin,

Journal:

Gastroenterology

Année:

2014

Langue:

english

Fichier:

PDF, 608 KB

english, 2014